Skip to main content
Erschienen in: Cancer Causes & Control 6/2014

01.06.2014 | Original paper

Cancer of unknown primary: time trends in incidence, United States

verfasst von: Elena Mnatsakanyan, Wei-Chen Tung, Brenna Caine, Julie Smith-Gagen

Erschienen in: Cancer Causes & Control | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the epidemiological features and trends of cancer of unknown primary (CUP) in a large and diverse US population.

Methods

The Surveillance Epidemiology and End Results registry was used to examine incidence rates, adjusted to the World Segi 1960 population, by demographic and tumor characteristics among patients diagnosed with CUP between 1973 and 2010. Annual percent changes in incidence rates were estimated using Joinpoint regression.

Results

The incidence rate of pathologically investigated CUP was 4.1 per 100,000 and is consistent with reports from other countries. In the USA, CUP incidence rates have been decreasing since the early 1980s, 3.6 % per year in the last two decades. The USA experienced decreases earlier than other countries. US males and African Americans had the highest rates of CUP. The rates of non-microscopically confirmed CUP have dropped 2.6 % per year since 1973, but 24 % of CUP patients do not receive microscopic confirmation and 21 % of those with microscopically investigated cancer receive a vague histology (i.e., epithelial) diagnosis. Twenty percent of patients with pathological investigation receive radiation. Patients were twice as likely to be diagnosed with a non-pathologically investigated CUP if they were living in areas with the lowest income quartile relative to areas with the highest income quartile.

Conclusion

Although the incidence of CUP is decreasing, we document CUP that may be due to insufficient diagnostic inquiry. Questions raised by the findings in this data provide hypotheses for further epidemiological and biological studies in the elucidation of CUP incidence and treatment.
Literatur
1.
Zurück zum Zitat Briasoulis E, Pavlidis N (1997) Cancer of unknown primary origin. Oncologist 2:142–152PubMed Briasoulis E, Pavlidis N (1997) Cancer of unknown primary origin. Oncologist 2:142–152PubMed
2.
Zurück zum Zitat Hainsworth JD, Greco FA (2009) Neoplasms of unknown primary site. In: Hong WK, Bast RC (eds) Holland Frei cancer medicine edition, 8th edn. Peoples Medical Publishing House, New York, pp 1713–1722 Hainsworth JD, Greco FA (2009) Neoplasms of unknown primary site. In: Hong WK, Bast RC (eds) Holland Frei cancer medicine edition, 8th edn. Peoples Medical Publishing House, New York, pp 1713–1722
3.
Zurück zum Zitat Shu X, Sundquist K, Sundquist J, Hemminki K (2012) Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev 21:281–288PubMedCrossRef Shu X, Sundquist K, Sundquist J, Hemminki K (2012) Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev 21:281–288PubMedCrossRef
4.
Zurück zum Zitat Greco A (2010) Evolving understanding and current management of patients with cancer of unknown primary site. Community Oncol 7:183–188CrossRef Greco A (2010) Evolving understanding and current management of patients with cancer of unknown primary site. Community Oncol 7:183–188CrossRef
5.
Zurück zum Zitat Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN (1995) Analysis of diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13:2094–2103PubMed Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN (1995) Analysis of diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13:2094–2103PubMed
7.
Zurück zum Zitat Naresh KN (2002) Do metastatic tumors from an unknown primary reflect angiogenic incompetence of the tumor at the primary site? A hypothesis. Med Hypothesis 59:357–360CrossRef Naresh KN (2002) Do metastatic tumors from an unknown primary reflect angiogenic incompetence of the tumor at the primary site? A hypothesis. Med Hypothesis 59:357–360CrossRef
9.
Zurück zum Zitat Randen M, Rutqvist LE, Johansson H (2009) Cancer patients without a known primary: incident and survival trends in Sweden 1960–2007. Clin Transl Oncol 8:915–920 Randen M, Rutqvist LE, Johansson H (2009) Cancer patients without a known primary: incident and survival trends in Sweden 1960–2007. Clin Transl Oncol 8:915–920
10.
Zurück zum Zitat Riihimaki M, Hemminki A, Sundquist K, Hemminki K (2013) Time trends in survival from cancer of unknown primary: small steps forward. Eur J Cancer 49:2403–2410PubMedCrossRef Riihimaki M, Hemminki A, Sundquist K, Hemminki K (2013) Time trends in survival from cancer of unknown primary: small steps forward. Eur J Cancer 49:2403–2410PubMedCrossRef
11.
Zurück zum Zitat Levi F, Te VC, Erler G, Randimbison L, La Vecchia C (2002) Epidemiology of unknown primary tumours. Eur J Cancer 38:1810–1812PubMedCrossRef Levi F, Te VC, Erler G, Randimbison L, La Vecchia C (2002) Epidemiology of unknown primary tumours. Eur J Cancer 38:1810–1812PubMedCrossRef
12.
Zurück zum Zitat Van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF (2002) Epidemiology of unknown primary tumours: incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992. Eur J Cancer 38:409–413PubMedCrossRef Van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF (2002) Epidemiology of unknown primary tumours: incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992. Eur J Cancer 38:409–413PubMedCrossRef
13.
Zurück zum Zitat Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications No, Lyon 160 Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications No, Lyon 160
15.
Zurück zum Zitat Blaszyk H, Hartmann A, Bjornsson J (2003) Cancer of unknown primary: clinicopathologic correlations. APMIS 111:1089–1094PubMedCrossRef Blaszyk H, Hartmann A, Bjornsson J (2003) Cancer of unknown primary: clinicopathologic correlations. APMIS 111:1089–1094PubMedCrossRef
16.
Zurück zum Zitat Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of unknown primary. Eur J Cancer 39:1990–2005PubMedCrossRef Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of unknown primary. Eur J Cancer 39:1990–2005PubMedCrossRef
17.
Zurück zum Zitat Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L (2013) Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer 109:1318–1324PubMedCrossRef Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L (2013) Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer 109:1318–1324PubMedCrossRef
19.
Zurück zum Zitat SEER Program Coding and Staging Manual 2004, Revision 1. Appendix C: Site Specific Coding Modules Part 3: C50.0–C80.9. Surveillance Systems Branch Surveillance Research Program Division Of Cancer Control And Population Sciences National Institutes Of Health Public Health Service U.S. Department of Health And Human Services. http://seer.cancer.gov/tools/codingmanuals/historical.html. Accessed 25 Jan 2014 SEER Program Coding and Staging Manual 2004, Revision 1. Appendix C: Site Specific Coding Modules Part 3: C50.0–C80.9. Surveillance Systems Branch Surveillance Research Program Division Of Cancer Control And Population Sciences National Institutes Of Health Public Health Service U.S. Department of Health And Human Services. http://​seer.​cancer.​gov/​tools/​codingmanuals/​historical.​html. Accessed 25 Jan 2014
20.
Zurück zum Zitat SEER Program Coding and Staging Manual 2007 with 2008 Revision. Appendix C: Site Specific Coding Modules, Part 6: C64.9–C80.9. Surveillance Systems Branch Surveillance Research Program Division Of Cancer Control And Population Sciences National Institutes Of Health Public Health Service U.S. Department Of Health And Human Services http://seer.cancer.gov/tools/codingmanuals/historical.html. Accessed 25 Jan 2014 SEER Program Coding and Staging Manual 2007 with 2008 Revision. Appendix C: Site Specific Coding Modules, Part 6: C64.9–C80.9. Surveillance Systems Branch Surveillance Research Program Division Of Cancer Control And Population Sciences National Institutes Of Health Public Health Service U.S. Department Of Health And Human Services http://​seer.​cancer.​gov/​tools/​codingmanuals/​historical.​html. Accessed 25 Jan 2014
21.
Zurück zum Zitat SEER Program Coding and Staging Manual 2010, Appendix C: Site Specific Coding Modules. Surveillance Systems Branch Surveillance Research Program Division of Cancer Control and Population Sciences National Institutes of Health Public Health Service Department of Health and Human Services. http://seer.cancer.gov/tools/codingmanuals/historical.html. Accessed 25 Jan 2014 SEER Program Coding and Staging Manual 2010, Appendix C: Site Specific Coding Modules. Surveillance Systems Branch Surveillance Research Program Division of Cancer Control and Population Sciences National Institutes of Health Public Health Service Department of Health and Human Services. http://​seer.​cancer.​gov/​tools/​codingmanuals/​historical.​html. Accessed 25 Jan 2014
23.
Zurück zum Zitat Morris DS, Weizer AZ, Ye Z, Dunn RL, Montie JE, Hollenbeck BK (2009) Understanding bladder cancer death: tumor biology versus physician practice. Cancer 115(5):1011–1020PubMedCrossRef Morris DS, Weizer AZ, Ye Z, Dunn RL, Montie JE, Hollenbeck BK (2009) Understanding bladder cancer death: tumor biology versus physician practice. Cancer 115(5):1011–1020PubMedCrossRef
25.
Zurück zum Zitat Cress RD, Zaslavsky AM, West DW, Wolf RE, Felter MC, Ayanian JZ (2003) Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 41:1006–1012PubMedCrossRef Cress RD, Zaslavsky AM, West DW, Wolf RE, Felter MC, Ayanian JZ (2003) Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 41:1006–1012PubMedCrossRef
26.
Zurück zum Zitat Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al (2007) Cancer incidence in five continents, Vol IX. IARC Scientific Publications, Lyon No. 1 Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al (2007) Cancer incidence in five continents, Vol IX. IARC Scientific Publications, Lyon No. 1
27.
Zurück zum Zitat Anderson RN, Rosenberg HM (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47(1–16):20 Anderson RN, Rosenberg HM (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47(1–16):20
28.
Zurück zum Zitat Jemal A, Ward E, Thun M (2005) Cancer statistics. In: DeVita VJ, Hellman S, Rosenberg S (eds) Cancer principles and practice of oncology, 7th edn. Lipppincott Williams & Wilkins, Baltimore, pp 226–240 Jemal A, Ward E, Thun M (2005) Cancer statistics. In: DeVita VJ, Hellman S, Rosenberg S (eds) Cancer principles and practice of oncology, 7th edn. Lipppincott Williams & Wilkins, Baltimore, pp 226–240
29.
Zurück zum Zitat Kim H-J, Fay MP, Yu B, Barrett MJ, Feuer EJ (2004) Comparability of segmented line regression models. Biometrics 60:1005–1014PubMedCrossRef Kim H-J, Fay MP, Yu B, Barrett MJ, Feuer EJ (2004) Comparability of segmented line regression models. Biometrics 60:1005–1014PubMedCrossRef
31.
Zurück zum Zitat Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D (2008) Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health 32:383–389PubMedCrossRef Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D (2008) Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health 32:383–389PubMedCrossRef
32.
Zurück zum Zitat Fehri R, Rifi H, Alboueiri A, Malouche D, Ayadi M, Rais H, Mezlini A (2013) Carcinoma of unknown primary: retrospective study about 437 patients treated at Salah Azaiez Institute. Tunis Med 91:205–208PubMed Fehri R, Rifi H, Alboueiri A, Malouche D, Ayadi M, Rais H, Mezlini A (2013) Carcinoma of unknown primary: retrospective study about 437 patients treated at Salah Azaiez Institute. Tunis Med 91:205–208PubMed
33.
Zurück zum Zitat Pavlidis N, Pentheroudakis G (2013) Cancer of unknown primary site. Lancet 379:1428–1435CrossRef Pavlidis N, Pentheroudakis G (2013) Cancer of unknown primary site. Lancet 379:1428–1435CrossRef
34.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER cancer statistics review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, 2013 Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER cancer statistics review, 1975–2010, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2010/​, based on November 2012 SEER data submission, posted to the SEER web site, 2013
35.
Zurück zum Zitat Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE (2009) Gastrointestinal malignancies: when does race matter? J Am Coll Surg 209:645–652PubMedCrossRef Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE (2009) Gastrointestinal malignancies: when does race matter? J Am Coll Surg 209:645–652PubMedCrossRef
37.
Zurück zum Zitat Yang W, Queadan F, Smith-Gagen J (2008) The Hispanic epidemiological paradox in the fastest growing state in the US. Hisp Health Care Int 7:130–141CrossRef Yang W, Queadan F, Smith-Gagen J (2008) The Hispanic epidemiological paradox in the fastest growing state in the US. Hisp Health Care Int 7:130–141CrossRef
38.
Zurück zum Zitat Borrell LN, Lancet EA (2012) Race/ethnicity and all-cause mortality in US adults: revisiting the Hispanic paradox. Am J Public Health 102:836–843PubMedCentralPubMedCrossRef Borrell LN, Lancet EA (2012) Race/ethnicity and all-cause mortality in US adults: revisiting the Hispanic paradox. Am J Public Health 102:836–843PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Brenner DJ, Hall EJ (2007) Computed tomography: an increasing source of radiation exposure. N Engl J Med 357:2277–2284PubMedCrossRef Brenner DJ, Hall EJ (2007) Computed tomography: an increasing source of radiation exposure. N Engl J Med 357:2277–2284PubMedCrossRef
40.
Zurück zum Zitat Levinson DR (2007) Growth in advanced imaging paid under the medicare physician fee schedule. Office of Inspector General. Department of Health and Human Services OEI-01-06-00260 Levinson DR (2007) Growth in advanced imaging paid under the medicare physician fee schedule. Office of Inspector General. Department of Health and Human Services OEI-01-06-00260
41.
Zurück zum Zitat Freedman DA, Petitti DB, Robins JM (2004) On the efficacy of screening for breast cancer. Int J Epidemiol 33:43–55PubMedCrossRef Freedman DA, Petitti DB, Robins JM (2004) On the efficacy of screening for breast cancer. Int J Epidemiol 33:43–55PubMedCrossRef
42.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2010) SEER cancer statistics review, 1975–2010, National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1975_2010. Accessed 3 Sept 2013 Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2010) SEER cancer statistics review, 1975–2010, National Cancer Institute Bethesda, MD http://​seer.​cancer.​gov/​csr/​1975_​2010. Accessed 3 Sept 2013
Metadaten
Titel
Cancer of unknown primary: time trends in incidence, United States
verfasst von
Elena Mnatsakanyan
Wei-Chen Tung
Brenna Caine
Julie Smith-Gagen
Publikationsdatum
01.06.2014
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 6/2014
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0378-2

Weitere Artikel der Ausgabe 6/2014

Cancer Causes & Control 6/2014 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.